Sagimet Biosciences Inc.
SGMT
$7.11
-$0.24-3.27%
NASDAQ
| 06/30/2025 | 03/31/2025 | ||||
|---|---|---|---|---|---|
| Revenue | -- | -- | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -- | -- | |||
| Cost of Revenue | -- | -- | |||
| Gross Profit | -- | -- | |||
| SG&A Expenses | 3.40% | 13.67% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -39.97% | 9.18% | |||
| Operating Income | 39.97% | -9.18% | |||
| Income Before Tax | 42.86% | -12.19% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | 42.86% | -12.19% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 42.86% | -12.19% | |||
| EBIT | 39.97% | -9.18% | |||
| EBITDA | -- | -- | |||
| EPS Basic | 42.86% | -12.20% | |||
| Normalized Basic EPS | 42.86% | -12.18% | |||
| EPS Diluted | 42.86% | -12.20% | |||
| Normalized Diluted EPS | 42.86% | -12.18% | |||
| Average Basic Shares Outstanding | 0.00% | 0.00% | |||
| Average Diluted Shares Outstanding | 0.00% | 0.00% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||